AMPH – amphastar pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
2 Russell 2000 Stocks for Long-Term Investors and 1 Facing Challenges [Yahoo! Finance]
Amphastar Pharmaceuticals (NASDAQ:AMPH) was upgraded by analysts at Barclays PLC to a "hold" rating.
Amphastar Pharmaceuticals (NASDAQ:AMPH) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $30.00 price target on the stock.
Amphastar Pharmaceuticals (AMPH) Stock Trades Up, Here Is Why [Yahoo! Finance]
Amphastar Pharmaceuticals (AMPH) Jumps 6.5% After Q3 Beat and Conference Reveal—Has the Investment Case Shifted? [Yahoo! Finance]
Form 144 Amphastar Pharmaceutical Filed by: Petersen Floyd F.
Form 144 Amphastar Pharmaceutical Filed by: Petersen Floyd F.
Form 144 Amphastar Pharmaceutical Filed by: Zhou Rong
Form 4 Amphastar Pharmaceutical For: Nov 25 Filed by: PRINS RICHARD K
Form 144 Amphastar Pharmaceutical Filed by: PRINS RICHARD K
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.